No abstract available
Publication types
-
Clinical Trial
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adaptor Proteins, Signal Transducing / metabolism*
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
LIM Domain Proteins / metabolism*
-
Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
-
Lymphoma, Large B-Cell, Diffuse* / drug therapy
-
Lymphoma, Large B-Cell, Diffuse* / metabolism
-
Lymphoma, Large B-Cell, Diffuse* / mortality
-
Male
-
Middle Aged
-
Positron Emission Tomography Computed Tomography*
-
Prednisone / administration & dosage
-
Proto-Oncogene Proteins / metabolism*
-
Rituximab / administration & dosage
-
Tumor Necrosis Factor Receptor Superfamily, Member 9 / metabolism*
-
Vincristine / administration & dosage
Substances
-
Adaptor Proteins, Signal Transducing
-
LIM Domain Proteins
-
LMO2 protein, human
-
Proto-Oncogene Proteins
-
R-CHOP protocol
-
TNFRSF9 protein, human
-
Tumor Necrosis Factor Receptor Superfamily, Member 9
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone